$ANF

ABERCROMBIE & FITCH CO /DE/

1
0
0

No SEC Form 4 filings for $ANF in the last 30 days.

See all $ANF insider activity →
Med

US Analyst Updates: October 22nd, 2026

Analysts remain cautiously optimistic, favoring utilities, healthcare, and infrastructure. 4D Molecular Therapeutics (FDMT) and Abbott Laboratories (ABT) received multiple ratings. ABT's price targets varied, with some raised and others lowered. Other notable updates include downgrades for Aegon (AEG) and Alcoa (AA), while Alphabet (GOOGL) saw a lowered target. Sector-specific trends and individual stock ratings reflect varying market outlooks.

Abercrombie & Fitch wins Jefferies backing as pricing power and brand momentum support growth

Jefferies maintains a 'buy' rating for Abercrombie & Fitch (ANF), citing strong brand momentum, pricing power, and disciplined discounting. The retailer reported 8% sales growth for its namesake brand and 2% for Hollister in Q2. AUR increased by a mid-single-digit percentage, and gross margin expanded by 850 basis points. The company expects continued growth and margin expansion.

Marvell, Skydance, Levi's, Alibaba and more analyst calls of the week

Analysts commented on several companies: UBS sees PepsiCo's valuation discount as unjustified despite slower North America recovery. Jefferies maintains 'buy' on Abercrombie & Fitch, citing growth potential. Reddit's ad share grew 20-25% annually. BofA initiates 'buy' on Penguin Solutions with $100 target. Alvopetro Energy gains backing for Brazil acreage. UBS keeps 'neutral' on Apple, citing iPhone 18 Pro demand concerns.

ANF sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning ANF (ABERCROMBIE & FITCH CO /DE/). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent ANF coverage spans financial news, earnings and macro economy.

What's driving ANF

AlphAI scores every news story that mentions ANF with an AI model for sentiment and relevance, and aggregates insider trades from ABERCROMBIE & FITCH CO /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ANF

Score

US Analyst Updates: October 22nd, 2026

Analysts remain cautiously optimistic, favoring utilities, healthcare, and infrastructure. 4D Molecular Therapeutics (FDMT) and Abbott Laboratories (ABT) received multiple ratings. ABT's price targets varied, with some raised and others lowered. Other notable updates include downgrades for Aegon (AEG) and Alcoa (AA), while Alphabet (GOOGL) saw a lowered target. Sector-specific trends and individual stock ratings reflect varying market outlooks.

Abercrombie & Fitch wins Jefferies backing as pricing power and brand momentum support growth

Jefferies maintains a 'buy' rating for Abercrombie & Fitch (ANF), citing strong brand momentum, pricing power, and disciplined discounting. The retailer reported 8% sales growth for its namesake brand and 2% for Hollister in Q2. AUR increased by a mid-single-digit percentage, and gross margin expanded by 850 basis points. The company expects continued growth and margin expansion.

Marvell, Skydance, Levi's, Alibaba and more analyst calls of the week

Analysts commented on several companies: UBS sees PepsiCo's valuation discount as unjustified despite slower North America recovery. Jefferies maintains 'buy' on Abercrombie & Fitch, citing growth potential. Reddit's ad share grew 20-25% annually. BofA initiates 'buy' on Penguin Solutions with $100 target. Alvopetro Energy gains backing for Brazil acreage. UBS keeps 'neutral' on Apple, citing iPhone 18 Pro demand concerns.

$ANFHigh

How Earnings Beat At Abercrombie & Fitch (ANF) Has Changed Its Investment Story

Abercrombie & Fitch (ANF) reported Q2 revenue and earnings above expectations, raising its fiscal 2026 outlook. The company cited brand momentum, merchandise execution, and disciplined inventory management. Management also filed a shelf registration for $98.65M of Class A stock tied to its employee stock ownership plan. Analysts project revenues of $5.9B and earnings of $504.8M by 2029, with some indicating a 10% potential downside.

Reflecting On Apparel Retailer Stocks’ Q2 Earnings: Abercrombie and Fitch (NYSE:ANF)

Zumiez (ZUMZ) reported $209M revenue, down 2.5% YoY, missing estimates. Guidance missed significantly. Stock down 19.4% to $13.46. Lululemon (LULU) reported $2.42B revenue, down 4.3% YoY, missing estimates. Guidance also missed. Stock down 18.9% to $98.79. Urban Outfitters (URBN) reported $1.66B revenue, up 10.4% YoY, beating estimates. Mixed quarter. Stock down 8.6% to $75.86.

$ZUMZMedAI 8/10

Winners And Losers Of Q2: Zumiez (NASDAQ:ZUMZ) Vs The Rest Of The Apparel Retailer Stocks

Tilly's (TLYS) reported $163.5M revenue, up 8.1% YoY, beating estimates and raising guidance. Its stock rose 18.1%. Lululemon (LULU) reported $2.42B revenue, down 4.3% YoY, missing estimates and guidance, with its stock falling 18.7%. Gap (GAP) reported $3.65B revenue, down 2% YoY, missing estimates but raising full-year EPS guidance, with its stock up 3.5%. Abercrombie & Fitch (ANF) reported $1.27B revenue, up 4.8% YoY, beating estimates and raising guidance, with its stock up 34.8%.

$CRMTMedAI 8/10

Mart, Zumiez, Macy's, Abercrombie and Fitch, and Victoria's Secret Shares Are Falling, What You Need To Know

Several retail stocks fell after August's Producer Price Index rose 5.4% YoY, driven by energy costs, and Brent crude oil surpassed $100/barrel, raising inflation concerns. Affected companies include Zumiez (ZUMZ, -4%), Macy's (M, -4.3%), Abercrombie & Fitch (ANF, -3.9%), and Victoria's Secret (VSXY, -4.2%). America's Car-Mart (CRMT, -4.8%) also declined, trading 96% below its 52-week high.

$ANFLow

ANF Initiates Coverage On Abercrombie & Fitch -- Rating Outperfo

BMO Capital initiated coverage on Abercrombie & Fitch Co (ANF) with an 'Outperform' rating and a $170.00 price target. ANF is currently trading at $151.43, which is 28.2% overvalued compared to its GF Value™ of $118.08. The company has a GF Score™ of 88/100, indicating strong overall performance. Insider activity shows significant selling, with $10,301,752 in insider sell value over the last three months.

Related tickers